Therapy for Syncope

Moya, Àngel

doi:10.1016/j.ccl.2015.04.015

Search citation statements

Order By: Relevance

Paper Sections

Select...

Issues Still To Be Resolved1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

2023

Publication Types

Select...

Article2

Book1

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 73 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The effectiveness of pharmacological treatment is also not well established. The use of beta-blockers (especially metoprolol) in older patients of 42 years can be effective, but there are no prospective, randomized, placebo-controlled studies focused on this population [6, 42]. …”

Section: Issues Still To Be Resolvedmentioning

confidence: 99%

The Current Indication for Pacemaker in Patients with Cardioinhibitory Vasovagal Syncope

Silva

Lisboa²

2016

TOCMJ

View full text Add to dashboard Cite

The most frequent cause of syncope is vasovagal reflex. It is associated with worse quality of life, depression, fatigue and physical injury. Recurrence of vasovagal syncope is an aggravating, reaching the rate of 69%. Initial step and pharmacological treatment may not work, especially in patients with recurrent syncope without prodrome. These patients can present cardioinhibitory response with asystole. Studies were designed to analyses the effectiveness of pacemaker for prevention of syncope. In this review, nonrandomized clinical trials, open-label randomized, double-blind randomized, placebo-controlled, and studies based on tilt test or Implantable Loop Recorder findings will be discussed.

show abstract

Section: Issues Still To Be Resolvedmentioning

confidence: 99%